سعر اتروبين 1% قطرة عين 10 مل 2024

Atropine sulfate 1% ophthalmic solution (eye drops), 10 ml bottle, manufactured in Egypt by Orchidia Pharmaceutical Industries; an antimuscarinic mydriatic and cycloplegic eye drop.

• CycloplegiaPopulation: Adults and children aged 3 months and olderDailyMed (U.S. National Library of Medicine)
• MydriasisPopulation: Adults and children aged 3 months and olderDailyMed (U.S. National Library of Medicine)
• Penalisation of the healthy eye in the treatment of amblyopiaPopulation: Adults and children aged 3 months and olderDailyMed (U.S. National Library of Medicine)

• Ocular: eye pain and stinging on instillation, blurred vision, photophobia, superficial keratitis, decreased lacrimation; less commonly allergic reactions such as papillary conjunctivitis, contact dermatitis and lid oedema.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Systemic (antimuscarinic): dryness of skin, mouth and throat; restlessness, irritability or delirium; tachycardia; flushing of the face and neck; increased heart rate and blood pressure.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Previous hypersensitivity or known allergic reaction to any ingredient of the formulation.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Photophobia and blurred vision due to pupil unresponsiveness and cycloplegia may last up to 2 weeks.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Elevation of blood pressure from systemic absorption has been reported after conjunctival instillation of recommended doses.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Risk of contamination: do not touch the dropper tip to the eye, eyelids or other surfaces.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Monoamine oxidase inhibitors (MAOIs)Concomitant use generally not recommended because of the potential to precipitate hypertensive crisis.DailyMed (U.S. National Library of Medicine)

• No adequate and well-controlled studies in pregnant women and no adequate animal reproduction studies; 1% atropine is systemically bioavailable after ocular use. Use in pregnancy only if the potential benefit justifies the potential risk to the fetus.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No information on the presence of atropine in human milk after ocular use or on effects on the breastfed infant or milk production; weigh the benefits of breastfeeding against the mother's need for the drug.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Atropine sulfate: Reversible competitive antagonist of acetylcholine at muscarinic receptors (M1-M3 not distinguished); blocks the muscarinic actions of acetylcholine on exocrine glands, smooth muscle and cardiac muscle.